CD8A and neoplasm: Properties of the immune system such as CD8 half-life, CD8 proliferation half-life, max CD8+ T cell influx rate, and the CTL-mediated tumor cell killing rate influenced response to anti-PD-(L)1 treatments (Figures 4B2,B3) but had no impact on tumor growth during control simulations (Figure 4B1).